Kim P, Garner N, Tatkovic A, Parsons R, Chunduri P, Vukovic J
NPJ Biol Timing Sleep. 2024; 1(1):13.
PMID: 39493889
PMC: 11530376.
DOI: 10.1038/s44323-024-00013-1.
Vazquez J, Gascue V, Quintana L, Migliaro A
J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2023; 210(1):7-18.
PMID: 37002418
DOI: 10.1007/s00359-023-01626-w.
Cardinali D, Brown G, Pandi-Perumal S
Nat Sci Sleep. 2022; 14:1843-1855.
PMID: 36267165
PMC: 9578490.
DOI: 10.2147/NSS.S380465.
Cruz-Sanabria F, Carmassi C, Bruno S, Bazzani A, Carli M, Scarselli M
Curr Neuropharmacol. 2022; 21(4):951-987.
PMID: 35176989
PMC: 10227911.
DOI: 10.2174/1570159X20666220217152617.
Owino S, Buonfiglio D, Tchio C, Tosini G
Front Endocrinol (Lausanne). 2019; 10:488.
PMID: 31379753
PMC: 6651071.
DOI: 10.3389/fendo.2019.00488.
Circadian Rhythm Disturbances in Mood Disorders: Insights into the Role of the Suprachiasmatic Nucleus.
Vadnie C, McClung C
Neural Plast. 2017; 2017:1504507.
PMID: 29230328
PMC: 5694588.
DOI: 10.1155/2017/1504507.
Understanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease.
Tosini G, Owino S, Guillaume J, Jockers R
Bioessays. 2014; 36(8):778-87.
PMID: 24903552
PMC: 4151498.
DOI: 10.1002/bies.201400017.
Randomized controlled trial of pharmacological replacement of melatonin for sleep disruption in individuals with tetraplegia.
Zeitzer J, Ku B, Ota D, Kiratli B
J Spinal Cord Med. 2013; 37(1):46-53.
PMID: 24090266
PMC: 4066551.
DOI: 10.1179/2045772313Y.0000000099.
Astakine 2--the dark knight linking melatonin to circadian regulation in crustaceans.
Watthanasurorot A, Saelee N, Phongdara A, Roytrakul S, Jiravanichpaisal P, Soderhall K
PLoS Genet. 2013; 9(3):e1003361.
PMID: 23555281
PMC: 3605217.
DOI: 10.1371/journal.pgen.1003361.
Familial circadian rhythm disorder in the diurnal primate, Macaca mulatta.
Zhdanova I, Masuda K, Bozhokin S, Rosene D, Gonzalez-Martinez J, Schettler S
PLoS One. 2012; 7(3):e33327.
PMID: 22413014
PMC: 3297643.
DOI: 10.1371/journal.pone.0033327.
Ramelteon prior to a short evening nap impairs neurobehavioral performance for up to 12 hours after awakening.
Cohen D, Wang W, Klerman E, Rajaratnam S
J Clin Sleep Med. 2011; 6(6):565-71.
PMID: 21206545
PMC: 3014243.
BIOLOGICAL TIMEKEEPING.
Gillette M, Abbott S
Sleep Med Clin. 2010; 4(2):99-110.
PMID: 21052483
PMC: 2967787.
DOI: 10.1016/j.jsmc.2009.01.005.
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.
Dubocovich M, Delagrange P, Krause D, Sugden D, Cardinali D, Olcese J
Pharmacol Rev. 2010; 62(3):343-80.
PMID: 20605968
PMC: 2964901.
DOI: 10.1124/pr.110.002832.
Melatonin inhibits hippocampal long-term potentiation.
Wang L, Suthana N, Chaudhury D, Weaver D, Colwell C
Eur J Neurosci. 2005; 22(9):2231-7.
PMID: 16262661
PMC: 2581482.
DOI: 10.1111/j.1460-9568.2005.04408.x.
Modulation of intercellular calcium signaling by melatonin in avian and mammalian astrocytes is brain region-specific.
Peters J, Earnest B, Tjalkens R, Cassone V, Zoran M
J Comp Neurol. 2005; 493(3):370-80.
PMID: 16261532
PMC: 2573039.
DOI: 10.1002/cne.20779.
Functional MT1 and MT2 melatonin receptors in mammals.
Dubocovich M, Markowska M
Endocrine. 2005; 27(2):101-10.
PMID: 16217123
DOI: 10.1385/ENDO:27:2:101.
Melatonin modulates the light-induced sympathoexcitation and vagal suppression with participation of the suprachiasmatic nucleus in mice.
Mutoh T, Shibata S, Korf H, Okamura H
J Physiol. 2003; 547(Pt 1):317-32.
PMID: 12562939
PMC: 2342619.
DOI: 10.1113/jphysiol.2002.028001.
Orphanin-FQ/nociceptin (OFQ/N) modulates the activity of suprachiasmatic nucleus neurons.
Allen C, Jiang Z, Teshima K, Darland T, Ikeda M, Nelson C
J Neurosci. 1999; 19(6):2152-60.
PMID: 10066268
PMC: 6782576.